Actiq 200 Micrograms Compressed Lozenge With Integral Oromucosal Applicator (Fentanyl) shortage — IE supply status & alternatives

Actiq 200 Micrograms Compressed Lozenge With Integral Oromucosal Applicator (Fentanyl)

—

In supply · Australia

In supply · 🇦🇺 Australia · short in🇮🇪 IE

In supply in Australia

Reading today’s signals…

✓ Can I substitute?

In supply

no shortage substitution needed

⇄ Best alternative

None listed

refer to prescriber

◷ Expected back

No estimate

No estimate provided

Product attributes reference data we hold

Active ingredient (INN)	Actiq 200 Micrograms Compressed Lozenge With Integral Oromucosal Applicator (Fentanyl)
Therapeutic category	Auto-created by HPRA (Health Products Regulatory Authority, Ireland) scraper
Controlled substance	No
Patient information leaflet (PIL)	Not on file
Summary of product characteristics (SPC)	Not on file

Trade price 🇦🇺 Australia · awaiting price ingest

🇦🇺 AU

Ex-manufacturer

—

Dispensed (DPMQ)

—

Pack

—

Not yet captured for Australia

Official pricing isn’t on file for this market yet. PBS (Australia), NHS Drug Tariff (United Kingdom) and CMS NADAC (United States) feeds are prioritised; this panel populates automatically once the data lands.

Substitution pathways 🇦🇺 Australia · TGA

—

No substitution instrument in force

Dispense per normal rules, or refer to the prescriber. No active SSSI/S19A instrument detected for this medicine.

How long have past shortages lasted? from 5 resolved events

◷

0–6 months

Historical pattern from resolved shortage records — not a prediction of this event.

Shortage status by regulator official notices

🇮🇪

Ireland

HPRA · 28d ago

Medium

🇪🇸

Spain

AEMPS · 6h ago

Resolved

Recalls official enforcement reports

🇺🇸

Actiq (Oral Transmucosal Fentanyl Citrate) 200 Mcg

Teva Pharmaceuticals USA, Inc. · May 2013

Class IIdetails ↗

Verified timeline regulator events

🇪🇸 10 Mar 2026

Shortage resolved

🇪🇸 8 Jan 2026

Shortage resolved

🇮🇪 18 Dec 2025

medium reported

🇪🇸 28 Oct 2025

Shortage resolved

🇪🇸 25 Aug 2025

Shortage resolved

🇪🇸 20 Aug 2025

Shortage resolved

Sources official regulators

🇪🇸

AEMPS

verified 6h ago

verify ↗

🇮🇪

HPRA

verified 28d ago

verify ↗

Mederti Drug Report

Generated 6 July 2026 · Australia market · 2 regulatory sources

For health-professional reference only. Mederti aggregates shortage and substitution information from official regulatory sources. It is not clinical advice and data may be incomplete or delayed. Confirm any substitution or supply decision against the primary regulator source, the prescriber, and current clinical references (e.g. AMH) before acting. Terms.